As of the 1st, KCB Pharmaceutical Korea appointed a new CEO, Edward Lee. Edward Lee, who has been an expert in market access, ...

At five years old, Idrees Qasim's tummy was so swollen he struggled to walk. When he wasn't in his pram, he wanted his mum ...

Provider-led I-SNPs have driven down resident hospitalizations, but their effect on other key clinical measures is questionable, a new study shows.

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

Both showed similar rates of blood pressure control, major adverse cardiovascular events, acute kidney injury and mortality ...

Grant Application Process Now Open for Up to $300,000 in Funding Align Technology, Inc. has announced the opening of its Annual Research Award Program to support clinical and scientific dental ...

As more individuals with T1D develop features of insulin resistance, new tools are needed to identify those at highest risk.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Use of sacubitril/valsartan in resistant hypertension will depend on strategies that integrate close monitoring and multidisciplinary care.

Servier India, the Indian arm of the French pharmaceutical group Servier, has launched a patient-centric biomarker testing ...

Robert Harshbarger Jr. pleaded guilty to one count of distributing a misbranded drug and one count of health care fraud.

Major clinical trial will prescribe stable dose of diazepam to drug users most at risk of overdose from street supply ...